Oral supplementation of melatonin attenuates the onset of alcohol-related liver disease
{{output}}
Studies suggest that supplementing melatonin in pharmacological doses may attenuate the development of liver diseases including alcohol-related liver diseases (ALD) in model organisms. If melatonin at "physiological" doses achievable through the intake of fo... ...
